Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosis.

Oliva J, Moreno S, Sanz J, Ribera E, Molina JA, Rubio R, Casas E, Mariño A.

AIDS. 2003 Mar 7;17(4):637-8. No abstract available.

PMID:
12598789
2.

Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.

Manosuthi W, Tantanathip P, Chimsuntorn S, Eampokarap B, Thongyen S, Nilkamhang S, Sungkanuparph S.

Int J Infect Dis. 2010 Nov;14(11):e1013-7. doi: 10.1016/j.ijid.2010.06.016. Epub 2010 Sep 28.

3.

Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.

Manosuthi W, Ruxrungtham K, Likanonsakul S, Prasithsirikul W, Inthong Y, Phoorisri T, Sungkanuparph S.

Clin Infect Dis. 2007 Jan 1;44(1):141-4. Epub 2006 Nov 21.

4.

Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.

Manosuthi W, Sungkanuparph S, Thakkinstian A, Rattanasiri S, Chaovavanich A, Prasithsirikul W, Likanonsakul S, Ruxrungtham K.

Clin Infect Dis. 2006 Jul 15;43(2):253-5. Epub 2006 Jun 12.

5.

Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.

van Oosterhout JJ, Kumwenda JJ, Beadsworth M, Mateyu G, Longwe T, Burger DM, Zijlstra EE.

Antivir Ther. 2007;12(4):515-21.

PMID:
17668560
6.

Do we still need lead-in dosing of nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy?

Chang SY, Lin SW, Hung CC.

Clin Infect Dis. 2009 Nov 1;49(9):1452-3; author reply 1453-4. doi: 10.1086/644494. No abstract available.

7.

Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.

Cohen K, van Cutsem G, Boulle A, McIlleron H, Goemaere E, Smith PJ, Maartens G.

J Antimicrob Chemother. 2008 Feb;61(2):389-93. Epub 2007 Dec 19.

8.

Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: a 144-week prospective study.

Manosuthi W, Tantanathip P, Prasithisirikul W, Likanonsakul S, Sungkanuparph S.

BMC Infect Dis. 2008 Oct 14;8:136. doi: 10.1186/1471-2334-8-136.

9.

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, Goemaere E, Coetzee D, Maartens G.

JAMA. 2008 Aug 6;300(5):530-9. doi: 10.1001/jama.300.5.530.

PMID:
18677025
10.

Outcomes and safety of concomitant nevirapine and rifampicin treatment under programme conditions in Malawi.

Moses M, Zachariah R, Tayler-Smith K, Misinde D, Foncha C, Manzi M, Bauerfeind A, Mwagomba B, Kwanjana J, Harries AD.

Int J Tuberc Lung Dis. 2010 Feb;14(2):197-202.

PMID:
20074411
11.

Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin.

Avihingsanon A, Manosuthi W, Kantipong P, Chuchotaworn C, Moolphate S, Sakornjun W, Gorowara M, Yamada N, Yanai H, Mitarai S, Ishikawa N, Cooper DA, Phanuphak P, Burger D, Ruxrungtham K.

Antivir Ther. 2008;13(4):529-36.

PMID:
18672531
12.

Reversible reduction of nevirapine plasma concentrations during rifampicin treatment in patients coinfected with HIV-1 and tuberculosis.

Matteelli A, Saleri N, Villani P, Bonkoungou V, Carvalho AC, Kouanda S, Sanou MJ, Simporé J, Monno L, Carosi G, Regazzi M, Dembele M.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):64-9.

PMID:
19731452
13.

Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.

Bhatt NB, Barau C, Amin A, Baudin E, Meggi B, Silva C, Furlan V, Grinsztejn B, Barrail-Tran A, Bonnet M, Taburet AM; ANRS 12146-CARINEMO Study Group.

Antimicrob Agents Chemother. 2014 Jun;58(6):3182-90. doi: 10.1128/AAC.02379-13. Epub 2014 Mar 24.

14.

Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).

Ribera E, Azuaje C, Lopez RM, Domingo P, Soriano A, Pou L, Sánchez P, Mallolas J, Sambea MA, Falco V, Ocaña I, Lopez-Colomes JL, Gatell JM, Pahissa A.

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):317-23.

PMID:
16249706
15.

Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.

Autar RS, Wit FW, Sankote J, Mahanontharit A, Anekthananon T, Mootsikapun P, Sujaikaew K, Cooper DA, Lange JM, Phanuphak P, Ruxrungtham K, Burger DM.

Antivir Ther. 2005;10(8):937-43.

PMID:
16430199
16.

Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.

Elsherbiny D, Cohen K, Jansson B, Smith P, McIlleron H, Simonsson US.

Eur J Clin Pharmacol. 2009 Jan;65(1):71-80. doi: 10.1007/s00228-008-0481-y. Epub 2008 Aug 27.

PMID:
18751690
17.

Rifampin and recurrence of tuberculosis among patients infected with HIV.

Lambert ML, Hasker E, Van Deun A, Roberfroid D, Van der Stuyft P.

Clin Infect Dis. 2003 Dec 15;37(12):1719-20; author reply 1720-2. No abstract available.

18.

Anti-HIV agents. Once-daily anti-HIV therapy in people co-infected with TB.

[No authors listed]

TreatmentUpdate. 2004 Apr-May;16(3):4-5. No abstract available.

PMID:
17219607
19.

Pursuing a diagnosis in a Caribbean man.

Gulick RM.

AIDS Clin Care. 1997 Aug;9(8):62-3.

PMID:
11364479
20.

Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in Zambia.

Mwinga A, Hosp M, Zulu I, Farthing MJ, Mulambo S, Kelly P.

AIDS. 2002 Mar 29;16(5):806-8. No abstract available.

PMID:
11964547
Items per page

Supplemental Content

Write to the Help Desk